Talc - Standard Medicament in the Treatment of Malignant Pleural Effusion
Authors:
M. Bednář; P. Bezdíček 1
Authors‘ workplace:
Ústav lékařské mikrobiologie 3. LF UK a FNKV, Praha, 1 Division of Pulmonary and Critical Care Medicine, The New York Hospital - Cornell University Medical College, New York, USA
Published in:
Čas. Lék. čes. 1999; : 82-84
Category:
Overview
Currently, talc is the most effective and widely-used agent for chemical pleurodesis in the treatment of bothmalignant pleural effusion and pneumothorax. Its popularity has been growing due to the low incidence of sideeffects, low cost and higher success rate in comparison with other agents (tetracyclines, bleomycin, Corynebacteriumparvum). The guidelines for talc pleurodesis are summarized and the history of the Corynebacterium parvum as anagent for chemical pleurodesis is mentioned. Its production in the Czech Republic has been halted due to the increasedinterest in the talc as a chemical sclerosant.
Key words:
malignant effusion, pneumothorax, pleurodesis, talc, Corynebacterium parvum, tetracyclin, bleomy-cin.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Talc - Standard Medicament in the Treatment of Malignant Pleural Effusion
- Budesonide (Turbuhaler), 400 mg/day, is at Least as Effective as a DoubleDose of Beclomethasone (MDI) in Patients with Mild to Medium Severe Bronchial Asthma
- Health Needs Assessment. Part 2. Need for Health and Need for Health Care
- Development of European Medicine up to Vesalius (16th century)